S'abonner

Modified obstetric early warning scoring systems (MOEWS): validating the diagnostic performance for severe sepsis in women with chorioamnionitis - 02/04/15

Doi : 10.1016/j.ajog.2014.11.007 
Sian E. Edwards, MBChB a, , William A. Grobman, MD, MBA e, Justin R. Lappen, MD f, Cathy Winter, RM c, Robert Fox, MD d, Erik Lenguerrand, PhD a, Timothy Draycott, MD b
a School of Clinical Sciences, University of Bristol, Bristol, United Kingdom 
b School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom 
c Research into Safety and Quality (RISQ), Southmead Hospital, Bristol, United Kingdom 
d Research into Safety and Quality (RISQ), Southmead Hospital, United Kingdom 
e Feinberg School of Medicine, Northwestern University, Chicago, IL 
f MetroHealth Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH 

Corresponding author: Sian E. Edwards, MBChB.

Abstract

Objective

We sought to compare the predictive power of published modified obstetric early warning scoring systems (MOEWS) for the development of severe sepsis in women with chorioamnionitis.

Study Design

This was a retrospective cohort study using prospectively collected clinical observations at a single tertiary unit (Chicago, IL). Hospital databases and patient records were searched to identify and verify cases with clinically diagnosed chorioamnionitis during the study period (June 2006 through November 2007). Vital sign data (heart rate, respiratory rate, blood pressure, temperature, mental state) for these cases were extracted from an electronic database and the single worst composite recording was identified for analysis. Global literature databases were searched (2014) to identify examples of MOEWS. Scores for each identified MOEWS were derived from each set of vital sign recordings during the presentation with chorioamnionitis. The performance of these MOEWS (the primary outcome) was then analyzed and compared using their sensitivity, specificity, positive and negative predictive values, and receiver-operating characteristic curve for severe sepsis.

Results

Six MOEWS were identified. There was wide variation in design and pathophysiological thresholds used for clinical alerts. In all, 913 women with chorioamnionitis were identified from the clinical database. In all, 364 cases with complete data for all physiological indicators were included in analysis. Five women developed severe sepsis, including 1 woman who died. The sensitivities of the MOEWS in predicting the severe deterioration ranged from 40–100% and the specificities varied even more ranging from 4–97%. The positive predictive values were low for all MOEWS ranging from <2–15%. The MOEWS with simpler designs tended to be more sensitive, whereas the more complex MOEWS were more specific, but failed to identify some of the women who developed severe sepsis.

Conclusion

Currently used MOEWS vary widely in terms of alert thresholds, format, and accuracy. Most MOEWS have not been validated. The MOEWS generally performed poorly in predicting severe sepsis in obstetric patients; in general severe sepsis was overdetected. Simple MOEWS with high sensitivity followed with more specific secondary testing is likely to be the best way forward. Further research is required to develop early warning systems for use in this setting.

Le texte complet de cet article est disponible en PDF.

Key words : chorioamnionitis, early warning systems, patient safety, sepsis


Plan


 The authors report no conflict of interest.
 Cite this article as: Edwards SE, Grobman WA, Lappen JR, et al. Modified obstetric early warning scoring systems (MOEWS): validating the diagnostic performance for severe sepsis in women with chorioamnionitis. Am J Obstet Gynecol 2015;212:536.e1-8.


© 2015  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 212 - N° 4

P. 536.e1-536.e8 - avril 2015 Retour au numéro
Article précédent Article précédent
  • Fetal DNA methylation of autism spectrum disorders candidate genes: association with spontaneous preterm birth
  • Fara Behnia, Sasha E. Parets, Talar Kechichian, Huaizhi Yin, Eryn H. Dutta, George R. Saade, Alicia K. Smith, Ramkumar Menon
| Article suivant Article suivant
  • A description of the methods of the Nulliparous Pregnancy Outcomes Study: monitoring mothers-to-be (nuMoM2b)
  • David M. Haas, Corette B. Parker, Deborah A. Wing, Samuel Parry, William A. Grobman, Brian M. Mercer, Hyagriv N. Simhan, Matthew K. Hoffman, Robert M. Silver, Pathik Wadhwa, Jay D. Iams, Matthew A. Koch, Steve N. Caritis, Ronald J. Wapner, M. Sean Esplin, Michal A. Elovitz, Tatiana Foroud, Alan M. Peaceman, George R. Saade, Marian Willinger, Uma M. Reddy, NuMoM2b study

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.